Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sinomab Bioscience Ltd (3681 HK)
Watchlist
12
Analysis
Health Care
•
Hong Kong
Sinomab Bioscience Limited manufactures antibody drugs. The Company researches, develops, and manufactures anti-infective drugs, antitumor agents, and monoclonal antibodies. Sinomab Bioscience markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Sinomab Bioscience Ltd
•
30 Oct 2019 16:12
SinoMab (中国抗体) IPO - A Hard Sell
SinoMab is a Hong Kong-based biotech company with a focus on mAb-based biologics for the treatment of immunological diseases, launched its book...
Ke Yan, CFA, FRM
Follow
532 Views
Share
bearish
•
Sinomab Bioscience Ltd
•
19 Jul 2019 11:28
SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy
SinoMab, the first Hong Kong-headquartered biotech company coming to list on the SEHK, plans to raise USD100 to 200 million. In this insight, we...
Ke Yan, CFA, FRM
Follow
665 Views
Share
First
Previous
1
2
3
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x